The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Urinalysis


Psychiatry related information on Urinalysis


High impact information on Urinalysis

  • MAIN OUTCOME MEASURES: Change from 1991 to 1997 in utilization rates of ESR, microscopic urinalysis, serum urea and iron determinations, and tests for total thyroxine and TSH [9].
  • At final assessment, patients in the high-dose condition reported using heroin 2.5 of 30 days as compared with 4.1 or 6.3 days for patients in the medium-dose and low-dose conditions, respectively (high dose vs low dose, P<.05); urinalysis results were similarly dose related [10].
  • We examined the results of the low-volume-laboratory proficiency testing program for new physician office participants in the Commonwealth of Pennsylvania. Serum glucose, hemoglobin, urinalysis, throat culture, urine culture, and Gram's stain were included in the study [11].
  • Probability of deterioration of renal function in these children was related to factors measurable at clinical presentation: (1) a corrected creatinine clearance of less than 25 mL/min/sq m; (2) 2r greater reaction for protein on urinalysis that disclosed no infection; and (3) being in less than the fifth percentile of body length [12].
  • MEASUREMENTS: Fasting lipid and apolipoprotein concentrations, including direct low-density lipoprotein (LDL) cholesterol quantification; nutritional analyses of 4 days of 7-day food records to monitor dietary compliance; and physical examinations, clinical chemistry and hematologic studies, and urinalysis to assess treatment safety [13].

Chemical compound and disease context of Urinalysis


Biological context of Urinalysis


Anatomical context of Urinalysis

  • Culture specimens and laboratory parameters including serum chemistry profile, complete blood cell count, and urinalysis were obtained before, during (every four to five days), and after ciprofloxacin therapy [24].
  • A cost-effective urinalysis test strategy, employing screening dipstick analysis with sediment microscopy performed on urines positive for leukocyte esterase, nitrite, protein, or blood, is evaluated [25].
  • Results of the Uristat test (Shield Diagnostics Ltd.), a novel enzyme-linked immunosorbent assay (ELISA) for detection of urine antibodies to seven common bacterial pathogens, were compared with results of urine culture, urinalysis, and clinical history to determine the usefulness of Uristat in the diagnosis of urinary tract infections (UTIs) [26].
  • Preliminary laboratory evaluation is usually done at the conclusion of the initial evaluation and generally includes a total or free testosterone level, a semen analysis, urinalysis, and screening profiles for blood count, liver and renal function, and serum electrolytes [27].
  • Metabolic panels and chest x-ray examinations were performed for the neonate and mother and the following values were measured: ANCA, erythrocyte sedimentation rate, C-reactive protein, antinuclear antibody, serial urinalysis, and complete blood cell count [28].

Associations of Urinalysis with chemical compounds

  • All patients earned incentives in the form of vouchers exchangeable for retail items contingent on cocaine-free urinalysis results during treatment weeks 1 to 12 [29].
  • Urinalyses showed the appearance of protein, bilirubin, RBCs, WBCs, and granular casts during therapy, which cleared completely on follow-up evaluation [30].
  • Urinalysis of lanthanum-loaded CRF animals showed a dose-dependent decrease in urinary phosphorus excretion, which was clearly more pronounced in the CRF groups compared with NRF animals [31].
  • Quantitative high resolution 1H NMR urinalysis studies on the biochemical effects of cadmium in the rat [32].
  • Urinalysis revealed increased heparan sulfate [33].

Gene context of Urinalysis

  • A total of 464 Japanese subjects, including 267 patients with histologically proven IgAN and 197 healthy controls with normal urinalysis, were genotyped for the NPHS1 G349A, G2289A, and T3315C polymorphisms [34].
  • The aim of this study was to investigate whether immunocytological urinalysis and monocyte chemoattractant protein-1 (MCP-1) assays could be used for an early diagnosis of nephropathy for patients with polyomavirus replication [35].
  • RESULTS: Urinalysis revealed significant increases in urinary protein and albumin in the ETA/ETB group when compared with all other groups [36].
  • We investigated whether the polymorphisms of C-509T and T869C in TGF-beta1 account for interindividual variation in manifestations of IgA nephropathy (IgAN) using 626 Japanese subjects including 329 patients with histologically proven IgAN and 297 healthy controls with normal urinalysis [37].
  • A strategy of combined urinalysis and urine culture in children with temperature > or = 39 degrees C is associated with the most favorable RB profile: preventive fraction = 0.45, RB1 = 5556; RB2 = 776 [38].

Analytical, diagnostic and therapeutic context of Urinalysis


  1. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. Sees, K.L., Delucchi, K.L., Masson, C., Rosen, A., Clark, H.W., Robillard, H., Banys, P., Hall, S.M. JAMA (2000) [Pubmed]
  2. A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Schena, F.P. Am. J. Med. (1990) [Pubmed]
  3. Acute renal impairment after immersion and near-drowning. Spicer, S.T., Quinn, D., Nyi Nyi, N.N., Nankivell, B.J., Hayes, J.M., Savdie, E. J. Am. Soc. Nephrol. (1999) [Pubmed]
  4. Measurement of urinary chemokine and growth factor messenger RNAs: a noninvasive monitoring in lupus nephritis. Avihingsanon, Y., Phumesin, P., Benjachat, T., Akkasilpa, S., Kittikowit, V., Praditpornsilpa, K., Wongpiyabavorn, J., Eiam-Ong, S., Hemachudha, T., Tungsanga, K., Hirankarn, N. Kidney Int. (2006) [Pubmed]
  5. Hypertension in the first month of life. Buchi, K.F., Siegler, R.L. J. Hypertens. (1986) [Pubmed]
  6. Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index. Strain, E.C., Stitzer, M.L., Liebson, I.A., Bigelow, G.E. Journal of clinical psychopharmacology. (1996) [Pubmed]
  7. Effect of methadone dose contingencies on urinalysis test results of polydrug-abusing methadone-maintenance patients. Stitzer, M.L., Bickel, W.K., Bigelow, G.E., Liebson, I.A. Drug and alcohol dependence. (1986) [Pubmed]
  8. Successful long-term treatment of congenital nephrogenic diabetes insipidus in a dog. Takemura, N. The Journal of small animal practice. (1998) [Pubmed]
  9. Effect of population-based interventions on laboratory utilization: a time-series analysis. van Walraven, C., Goel, V., Chan, B. JAMA (1998) [Pubmed]
  10. Dose-related efficacy of levomethadyl acetate for treatment of opioid dependence. A randomized clinical trial. Eissenberg, T., Bigelow, G.E., Strain, E.C., Walsh, S.L., Brooner, R.K., Stitzer, M.L., Johnson, R.E. JAMA (1997) [Pubmed]
  11. Longitudinal study of error prevalence in Pennsylvania physicians' office laboratories. Bloch, M.J., Cembrowski, G.S., Lembesis, G.J. JAMA (1988) [Pubmed]
  12. Vesicoureteral reflux in children with uremia. Prognostic indicators for treatment and survival. Berger, R.E., Ansell, J.S., Shurtleff, D.B., Hickman, R.O. JAMA (1981) [Pubmed]
  13. Efficacy of psyllium in reducing serum cholesterol levels in hypercholesterolemic patients on high- or low-fat diets. Sprecher, D.L., Harris, B.V., Goldberg, A.C., Anderson, E.C., Bayuk, L.M., Russell, B.S., Crone, D.S., Quinn, C., Bateman, J., Kuzmak, B.R., Allgood, L.D. Ann. Intern. Med. (1993) [Pubmed]
  14. Effects of combination cyclosporine/mizoribine immunosuppression on canine renal allograft recipients. Gregory, C.R., Gourley, I.M., Cain, G.R., Broaddus, T.W., Cowgill, L.D., Willits, N.H., Patz, J.D., Ishizaki, G. Transplantation (1988) [Pubmed]
  15. Transrectal ultrasonography in the evaluation of the infertile man: a report of 3 cases. Patterson, L., Jarow, J.P. J. Urol. (1990) [Pubmed]
  16. Effect of recombinant erythropoietin therapy on autoimmunity in systemic lupus erythematosus. Hebert, L.A., Birmingham, D.J., Shen, X.P., Brandt, J.T., Sedmak, D.D., Dillon, J.J. Am. J. Kidney Dis. (1994) [Pubmed]
  17. Imaging characteristics of indinavir calculi. Schwartz, B.F., Schenkman, N., Armenakas, N.A., Stoller, M.L. J. Urol. (1999) [Pubmed]
  18. Asymptomatic Chlamydia trachomatis urethritis in men. Stamm, W.E., Cole, B. Sexually transmitted diseases. (1986) [Pubmed]
  19. Safety of famciclovir in patients with herpes zoster and genital herpes. Saltzman, R., Jurewicz, R., Boon, R. Antimicrob. Agents Chemother. (1994) [Pubmed]
  20. Prospective cost analysis of moxalactam versus clindamycin plus gentamicin for endomyometritis after cesarean section. Knodel, L.C., Goldspiel, B.R., Gibbs, R.S. Antimicrob. Agents Chemother. (1988) [Pubmed]
  21. Tolerability, safety and pharmacokinetics of single dose and multiple dosing of the selective D1 antagonist NNC 01-0687 in healthy subjects. Skrumsager, B.K., Christensen, J.V., Snel, S., Seiberling, M. Psychopharmacology (Berl.) (1995) [Pubmed]
  22. Fetal cocaine exposure and neonatal bilirubinemia. Wennberg, R.P., Yin, J., Miller, M., Maynard, A. J. Pediatr. (1994) [Pubmed]
  23. The role of theophylline in contrast-induced nephropathy: a case-control study. Kapoor, A., Kumar, S., Gulati, S., Gambhir, S., Sethi, R.S., Sinha, N. Nephrol. Dial. Transplant. (2002) [Pubmed]
  24. Treatment of sepsis in patients with neoplastic diseases with intravenous ciprofloxacin. Brown, A.E., Smith, G. Am. J. Med. (1989) [Pubmed]
  25. Urine screening strategy employing dipstick analysis and selective culture: an evaluation. Loo, S.Y., Scottolini, A.G., Luangphinith, S., Adam, A.L., Jacobs, L.D., Mariani, A.J. Am. J. Clin. Pathol. (1984) [Pubmed]
  26. Efficacy of an enzyme-linked immunosorbent assay for detection of urinary tract immunoglobulins for diagnosis of urinary tract infections. Kellogg, J.A., Manzella, J.P., Seiple, J.W., Fortna, S.J., Cook, J.W., Levisky, J.S. J. Clin. Microbiol. (1992) [Pubmed]
  27. History and physical examination. Clark, R.V. Endocrinol. Metab. Clin. North Am. (1994) [Pubmed]
  28. Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement. Bansal, P.J., Tobin, M.C. Ann. Allergy Asthma Immunol. (2004) [Pubmed]
  29. Community reinforcement therapy for cocaine-dependent outpatients. Higgins, S.T., Sigmon, S.C., Wong, C.J., Heil, S.H., Badger, G.J., Donham, R., Dantona, R.L., Anthony, S. Arch. Gen. Psychiatry (2003) [Pubmed]
  30. Renal dysfunction associated with the administration of high-dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal carcinoma. Guleria, A.S., Yang, J.C., Topalian, S.L., Weber, J.S., Parkinson, D.R., MacFarlane, M.P., White, R.L., Steinberg, S.M., White, D.E., Einhorn, J.H. J. Clin. Oncol. (1994) [Pubmed]
  31. Does the phosphate binder lanthanum carbonate affect bone in rats with chronic renal failure? Behets, G.J., Dams, G., Vercauteren, S.R., Damment, S.J., Bouillon, R., De Broe, M.E., D'Haese, P.C. J. Am. Soc. Nephrol. (2004) [Pubmed]
  32. Quantitative high resolution 1H NMR urinalysis studies on the biochemical effects of cadmium in the rat. Nicholson, J.K., Higham, D.P., Timbrell, J.A., Sadler, P.J. Mol. Pharmacol. (1989) [Pubmed]
  33. Multiple sulfatase deficiency: clinical, neuropathological, ultrastructural and biochemical studies. Guerra, W.F., Verity, M.A., Fluharty, A.L., Nguyen, H.T., Philippart, M. J. Neuropathol. Exp. Neurol. (1990) [Pubmed]
  34. Genetic polymorphism of NPHS1 modifies the clinical manifestations of Ig A nephropathy. Narita, I., Goto, S., Saito, N., Song, J., Kondo, D., Omori, K., Kawachi, H., Shimizu, F., Sakatsume, M., Ueno, M., Gejyo, F. Lab. Invest. (2003) [Pubmed]
  35. Immunocytological urinalysis and monocyte chemotactic peptide-1 in renal transplant recipients with polyomavirus replication. Boratyńska, M., Dubiński, B., Rybka, K., Jezior, D., Szyber, P., Klinger, M. Transplant. Proc. (2006) [Pubmed]
  36. Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function. Forbes, J.M., Hewitson, T.D., Becker, G.J., Jones, C.L. Kidney Int. (2001) [Pubmed]
  37. Transforming growth factor-beta1 gene polymorphism modifies the histological and clinical manifestations in Japanese patients with IgA nephropathy. Sato, F., Narita, I., Goto, S., Kondo, D., Saito, N., Ajiro, J., Saga, D., Ogawa, A., Kadomura, M., Akiyama, F., Kaneko, Y., Ueno, M., Sakatsume, M., Gejyo, F. Tissue Antigens (2004) [Pubmed]
  38. Urine testing in young febrile children: a risk-benefit analysis. Kramer, M.S., Tange, S.M., Drummond, K.N., Mills, E.L. J. Pediatr. (1994) [Pubmed]
  39. Cephalothoracic lipodystrophy with hypocomplementemic renal disease: discordance in identical twin sisters. Bier, D.M., O'Donnell, J.J., Kaplan, S.L. J. Clin. Endocrinol. Metab. (1978) [Pubmed]
  40. The development of proteinuria and focal-segmental glomerulosclerosis in recipients of pediatric donor kidneys. Hayes, J.M., Steinmuller, D.R., Streem, S.B., Novick, A.C. Transplantation (1991) [Pubmed]
  41. Renal tolerance of a neutral gadolinium chelate (gadobutrol) in patients with chronic renal failure: results of a randomized study. Tombach, B., Bremer, C., Reimer, P., Kisters, K., Schaefer, R.M., Geens, V., Heindel, W. Radiology. (2001) [Pubmed]
  42. The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of followup, does it work? Kaplan, S.A., Olsson, C.A., Te, A.E. J. Urol. (1996) [Pubmed]
  43. Estimating the prevalence of drug use from self-reports in a cohort for which biologic data are available for a subsample. Poole, W.K., Flynn, P.M., Rao, A.V., Cooley, P.C. Am. J. Epidemiol. (1996) [Pubmed]
WikiGenes - Universities